Stay updated on Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial page.

Latest updates to the Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedPage revision label updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 on the page, indicating a minor document update.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2; no substantive study content, endpoints, or locations were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision label changed from v3.4.0 to v3.4.1 with no impact on content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check80 days agoChange DetectedAdded standalone 'Results First Posted' and 'Last Update Posted' timestamps and removed the '(Estimated)' qualifiers for those fields. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check88 days agoChange DetectedThe page now shows Revision: v3.3.4, replacing the previous Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial page.